A Algra, ESPRIT Study Group - The Lancet Neurology, 2007 - Elsevier
Background Oral anticoagulants are better than aspirin for secondary prevention after
myocardial infarction and after cerebral ischaemia in combination with non-rheumatic atrial
fibrillation. The European/Australasian Stroke Prevention in Reversible Ischaemia Trial
(ESPRIT) aimed to determine whether oral anticoagulation with medium intensity is more
effective than aspirin in preventing future vascular events in patients with transient ischaemic
attack or minor stroke of presumed arterial origin. Methods In this international, multicentre …